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INTRODUCTION
With an increase in the incidence of transnational marriage, 
Korean society has moved rapidly toward becoming a multi-
cultural society. According to statistics published by Statistics 
Korea in 2016, the number of female marriage immigrants grad-
ually increased from 127540 in 2012 to 128518 in 2016 (http://
index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2819).1 
The majority of transnational marriages in Korea takes place 
between Korean men and women from other Asian countries, 
where, with the exception of Japan, the prevalence of viral hep-
atitis is similar to or somewhat higher than that of Korea.2-6
Hepatitis A virus (HAV) is usually transmitted via polluted 
water and contaminated food, and seroprevalence is depen-
dent on age and level of hygiene.7 Especially, since one’s first 
exposure to HAV during adulthood can lead to severe and fatal 
acute hepatitis, it is important to identify susceptible individu-
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als, particularly women of childbearing age, who are likely to 
be female marriage immigrants.8-10 It is possible that the prev-
alence of hepatitis B virus (HBV) in immigrants reflects infec-
tion patterns present in their own countries.11,12 Although early 
and timely vaccinations for those at risk could prevent diseases 
caused by HAV and HBV, the seroprevalence of hepatitis vi-
ruses in multicultural families has not yet been investigated in 
real-life situations.
HBV strains have been classified into eight well-known gen-
otypes (A–H), and two new genotypes, I and J, have recently 
been identified.13,14 HBV genotypes are related to disease pro-
gression, clinical outcome, response to antiviral treatment, and 
prognosis.15 Therefore, determination of specific genotypes 
may be important in the clinical management of HBV infec-
tion. Geographic distributions of HBV genotypes are distinc-
tive, and genotypes B and C are prevalent in the Asian-Pacific 
region.15 Genotype C is more common than genotype B in Chi-
na and Japan, whereas the opposite is true in Taiwan and Viet-
nam.16 While almost all HBV strains have been identified as 
genotype C in Korea,17,18 there is no available data concerning 
HBV genotypes in multicultural families.
The total global prevalence of anti-hepatitis C virus (HCV) is 
estimated to be 1.6%,19 which is higher than the prevalence in 
Korea (0.78%).20 Even if HCV prevalence may decrease in the 
near future due to oral antiviral agents, a better knowledge of the 
prevalence of anti-HCV positivity in female marriage immigrants 
may help physicians control and prevent HCV infection.
This study aimed to estimate the seroprevalence of hepatitis 
viruses and investigate HBV genotypic diversity in female 
marriage immigrants.
MATERIALS AND METHODS
Study population
Free screening program was conducted at support centers 
for multicultural families in 21 administrative districts in Ko-
rea (Gangdong-gu, Gangseo-gu, Geumcheon-gu, Guro-gu, 
Gwangjin-gu, Seongbuk-gu, and Yeongdeungpo-gu in Seoul; 
Anyang, Ansan, Icheon, Gunpo, Pyeongtaek, Gimpo, Gwang-
myeong in Gyeonggi-do; Jangseong, Gokseong in Jeollanam-
do; Bukgu, Sasanggu in Busan; Seosan in Chungcheongnam-
do; Tongyeong in Gyeongsangnam-do; and Hongcheon in 
Gangwon-do). Nine hundred sixty three individuals in trans-
national marriages participated in the program between July 
2011 and January 2017. Blood samples were tested for amino-
transferase, IgG anti-HAV, HBsAg, anti-HBs, and anti-HCV. 
The following data were collected from all subjects: demo-
graphic information (e.g., age and sex), and original nationali-
ty. To study IgG anti-HAV seroprevalence according to age, 
patients were stratified into the following two age groups: 20–
29 and 30–40 years. The study protocol conformed to ethical 
guidelines of the 1975 Declaration of Helsinki, and was ap-
proved by the Institutional Review Board of Chung-Ang Uni-
versity College of Medicine [IRB No. C2015178 (1636)]. In addi-
tion, written informed consent was obtained from each patient.
Definitions and laboratory tests
Anti-HAV seropositivity was established if serum IgG anti-
HAV was positive, HBV infection was diagnosed if HBsAg was 
positive, and anti-HCV seropositivity was defined if serum 
anti-HCV was positive in a second-generation enzyme immu-
noassay. Commercially available enzyme immunoassay kits 
were used to detect serum IgG anti-HAV (bioMérieux SA, Mar-
cy-l’Etoile, France) and anti-HCV (Roche, Mannheim, Ger-
many). HBV serologic markers (HBsAg, anti-HBs) were tested 
via radioimmunoassay or enzyme-linked immunoassay, us-
ing commercial assays (Abbott Laboratories, Sligo, Ireland). 
HBeAg and anti-HBe were tested via radioimmunoassay or 
enzyme-linked immunoassay, using commercial assays (Ab-
bott Laboratories).
Determination of HBV DNA titer and genotypes
Among 52 subjects who were HBsAg-positive, written informed 
consent on HBV DNA genotyping, HBeAg, and anti-HBe was 
obtained from 28 subjects. Among these 28 subjects, 22 sub-
jects showed detectable HBV DNA levels and six subjects 
showed undetectable HBV DNA level. Serum HBV DNA con-
centration was determined by a commercially available quan-
titative assay (Lightcycler 2.0; Roche Diagnostics, Branchburg, 
NJ, USA). The lower limit of sensitivity of assay was 116 cop-
ies/mL. With respect to genotyping, a phylogenetic analysis 
based on entire sequences of the entire HBs region was per-
formed for subjects with detectable HBV DNA (n=22). Nucle-
otide sequences of HBV strains were compared to those of 
reference strains representing genotypes B and C obtained 
from GenBank (Accession numbers AB010290.B1, AB073830.
B2, AB73823.B2, M54923.B3, AY033072.B4, AB073835.B4, 
AB219429.B5, AY123041.C1, AY217371.C1, AB205124.C2, X756 
56.C3, X75666.C3). A maximum likelihood phylogenetic tree 
was constructed using MEGA (version 5).
Statistics
Seroprevalence of hepatitis viruses was expressed as number 
of positive/number of tested subjects (percentage), according 
to country or region. In particular, seropositivity of IgG HAV 
was stratified according to age group, country, or region. 
RESULTS
Patient characteristics
Baseline characteristics of the subjects are shown in Table 1. A 
total of 963 female marriage immigrants were included in this 
study. They participated in the free hepatitis screening pro-
gram conducted by Chung-Ang University Hospital between 
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July 2011 and January 2017. Subjects’ median age was 33 years 
(20–40), consisting of women from nine countries including 
Vietnam (n=422, 43.8%), China (n=311, 32.3%), the Philippines 
(n=85, 8.8%), Cambodia (n=58, 6.0%), Japan (n=39, 4.0%), Uz-
bekistan (n=18, 1.9%), Mongolia (n=13, 1.3%), Thailand (n=10, 
1.0%), and Kazakhstan (n=7, 0.7%).
Seroprevalence of IgG anti-HAV according to age group
Of 963 subjects, 675 (70.1%) were positive for IgG anti-HAV 
and 288 (29.9%) required HAV vaccination. Seroprevalence of 
IgG anti-HAV according to country, region, and age is present-
ed in Table 2. All 71 subjects from Cambodia and Mongolia 
were shown to be positive for IgG anti-HAV, and IgG anti-HAV 
was highly prevalent in subjects from Uzbekistan, Kazakhstan, 
the Philippines, Vietnam, and China. In contrast, only 15.4% (6 
of 39) subjects from Japan showed positive for IgG anti-HAV. 
Seroprevalence of IgG anti-HAV increased with age. In subre-
gions of Asia, IgG anti-HAV seroprevalence was high in mem-
bers of multicultural families from Central, Southeast, and 
East Asia, except Japan (Fig. 1).
Seroprevalence of hepatitis B virus
Overall, 52 (5.4%) subjects were positive for HBsAg. Rates of 
positive HBsAg were the highest in subjects from Vietnam 
(7.6%, n=32), followed by those from Cambodia (6.9%, n=4) 
and China (4.2%, n=13), among countries with more than 50 
subjects (Table 3). Five hundred eighty-two (60.4%) subjects 
were positive for anti-HBs. In addition, 329 (34.2%) subjects 
who required HBV vaccination presented negative for anti-
HBs and HBsAg.
HBV DNA levels and genotypes
Among the 52 HBV-infected subjects, blood samples were 
available for 28 subjects. 
Nine subjects were positive for HBeAg; their mean age was 
30 years (range: 25–36 years), and mean HBV DNA level was 
636958527 copies/mL (120680–3472000000 copies/mL). Four 
Fig. 1. Seroprevalence of IgG anti-HAV in female marriage immigrants 
according to subregion of Asia. Female marriage immigrants from Central 
Asia, Southeast Asia, and East Asia showed high seroprevalence of IgG 
anti-HAV. Seroprevalence of IgG anti-HAV increased with age. *East Asia: 
China (n=311) and Japan (n=39), †Southeast Asia: Vietnam (n=422), Philip-
pines (n=85), Cambodia (n=58), and Thailand (n=10), ‡Central Asia: Uzbeki-
stan (n=18), Kazakhstan (n=7), and Mongolia (n=13). HAV, hepatitis A virus.
Table 1. Baseline Demographic and Clinical Characteristics
Clinical characteristics Immigrants (n=963)
Female marriage immigrants 963 (100)
Mean age (yr) 32.7 (±4.7)
Nationalities
East Asia 350 (36.3)
China 311 (32.3)
Japan 39 (4.0)
Southeast Asia 575 (59.7)
Vietnam  422 (43.8)
Philippines 85 (8.8)
Cambodia 58 (6.0)
Thailand 10 (1.0)
Central Asia 38 (3.9)
Uzbekistan 18 (1.9)
Mongolia 13 (1.3)
Kazakhstan 7 (0.7)
Viral markers
IgG Anti-HAV (+) 675 (70.1)
HBsAg (+)/Anti-HBs (-) 52 (5.4)
HBsAg (-)/Anti-HBs (+) 582 (60.4)
HBsAg (-)/Anti-HBs (-) 329 (34.2)
Anti-HCV (+) 8 (0.8)
SD, standard deviation.
Values are expressed as mean (±SD) or number (percentage).
Table 2. Seroprevalence of IgG Anti-HAV in Female Marriage Immigrants
Region 20–29 yrs 30–40 yrs All
East Asia 9/23 (39.1) 205/327 (62.7) 214/350 (61.1)
China 8/21 (38.1) 200/290 (69.0) 208/311 (66.9)
Japan 1/2 (50.0) 5/37 (13.5) 6/39 (15.4)
Southeast Asia 151/233 (64.8) 274/342 (80.1) 425/575 (73.9)
Vietnam 108/183 (59.0) 192/239 (80.3) 300/422 (71.1)
Philippines 21/27 (77.8) 42/58 (72.4) 63/85 (74.1)
Cambodia 22/22 (100) 36/36 (100) 58/58 (100)
Thailand 0/1 (0) 4/9 (44.4) 4/10 (40.0)
Central Asia 7/8 (87.5) 29/30 (96.7) 36/38 (94.7)
Uzbekistan 4/4 (100) 13/14 (92.9) 17/18 (94.4)
Mongolia - 13/13 (100) 13/13 (100)
Kazakhstan 3/4 (75.0) 3/3 (100) 6/7 (85.7)
Total 167/264 (63.3) 508/699 (72.7) 675/963 (70.1)
Values are expressed as number of positive/number of tested subjects (per-
centage) in each group.
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subjects were categorized into immune tolerant phase [high 
HBV DNA levels (7560000–3472000000 copies/mL) and nor-
mal ALT (<40 IU/L)]. Five subjects were categorized into im-
mune active phase [high HBV DNA levels (120680–752000000 
copies/mL) and high ALT (>80 IU/L)], and required antiviral 
therapy.
Nineteen subjects presented negative for HBeAg; their 
mean age was 35 (range: 27–40), and mean HBV DNA level 
was 16323 copies/mL (<116–52432 copies/mL). Five subjects 
were categorized into immune escape phase [elevated HBV 
DNA levels (11832–52432 copies/mL) and high ALT (>40 IU/
L)], and required antiviral therapy. Eight subjects had serum 
HBV DNA levels ranging from 116 copies/mL to 10000 copies/
mL, and ALT was normal. Six subjects had undetectable HBV 
DNA level (lower limit of HBV DNA: <116 copies/mL) and nor-
mal ALT. These 14 subjects were categorized into immune con-
trol phase.
HBV genotypes were available in 22 subjects with detect-
able HBV DNA. Their phylogenic tree is shown in Fig. 2. Gen-
otypes B and C were found in 54.6% (n=12) and 45.4% (n=10) 
of the subjects, respectively. As mentioned previously, geno-
type C was more common in China (n=8, 80%), and genotype 
B was more common in Vietnam (n=7, 58.3%) and Cambodia 
(n=3, 25%).
Seroprevalence of hepatitis C virus
Eight (0.8%) subjects were positive for anti-HCV. Seropreva-
lence of anti-HCV was high in subjects from Central Asia (n=3, 
7.9%) (Table 3). None of the subjects presented positive for 
HBV and HCV coinfection.
DISCUSSION
For the first time, this study investigated the seroepidemiology 
of hepatitis viruses and hepatitis B genotypes in female mar-
riage immigrants in Korea. Of a total of 963 subjects, 52 (5.4%) 
Table 3. Seroprevalence of HBV and HCV in Female Marriage Immigrants
Region Number HBsAg (+) Anti-HBs (+) Anti-HCV (+)
East Asia 350 13 (3.7) 237 (67.7) 2 (0.6)
China 311 13 (4.2) 219 (70.4) 2 (0.6)
Japan 39 0 (0) 18 (46.2) 0 (0)
Southeast Asia 575 38 (6.6) 323 (56.2) 3 (0.5)
Vietnam 422 32 (7.6) 249 (59.0) 2 (0.5)
Philippines 85 1 (1.2) 43 (50.6) 1 (1.2)
Cambodia 58 4 (6.9) 29 (50.0) 0 (0)
Thailand 10 1 (10.0) 2 (20.0) 0 (0)
Central Asia 38 1 (2.6) 22 (57.9) 3 (7.9)
Uzbekistan 18 0 (0) 13 (72.2) 1 (5.6)
Mongolia 13 0 (0) 8 (61.5) 2 (15.4)
Kazakhstan 7 1 (14.3) 1 (14.3) 0 (0)
Total 963 52 (5.4) 582 (60.4) 8 (0.8)
HBV, hepatitis B virus; HCV, hepatitis C virus.
Values are expressed as number of positive/number of tested subjects (per-
centage) in each group.
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was positive for HBsAg, and eight (0.8%) was positive for anti-
HCV. HAV and HBV vaccinations were required for 288 
(29.9%) and 329 (34.2%) subjects, respectively. In particular, 
HBV genotypes were available in 22 HBsAg-positive subjects. 
Genotype B (n=12, 54.6%) was found in a slightly higher num-
ber of female marriage immigrants compared to genotype C 
(n=10, 45.4%).
Prior to 1990, majority of Koreans had acquired natural im-
munity to HAV by their 20s.21 With improvements in socioeco-
nomic status, opportunities for exposure have decreased; 
consequently, rates of childhood HAV infection have reduced 
remarkably, and severe symptomatic hepatitis A infection in 
adolescents and adults has increased over the last 10 years.22,23 
In 2015, recent data indicated that the seropositive rate of IgG 
anti-HAV in 15–29 age group was still low (15–19 years, 22.7%; 
20–24 years, 18.4%; 25–29 years, 16.3%; 30–34 years, 26%; 35–
39 years, 54.8%).24 Especially, seropositive rate of IgG anti-HAV 
in 20–29 age group was reported to be only 18%, and 71.3–84% 
of acute hepatitis A occur in this age group.21 Therefore, Korean 
adults younger than 30 years of age should be vaccinated with-
out antibody testing, and those of age 30 years or older should 
be vaccinated in cases involving negative serologic tests.25  
In contrast, seroprevalence of IgG anti-HAV was significant-
ly higher in female marriage immigrants from Asian countries 
(20–29 years, 63.3%; 30–40 years, 72.7%). Interestingly, in female 
marriage immigrants from Japan, only six subjects (15.4%) 
were immune to HAV in the age group under 40 years. This 
variance may reflect differences in HAV seroepidemiology in 
the subjects’ own countries.26 Several studies have suggested 
that differences in seroprevalence can be attributed to geo-
logical, environmental, and socioeconomic conditions rather 
than ethnicity.27 Fortunately, safe and efficacious vaccine is 
available, providing an opportunity to lower disease burden 
and potentially eliminate infection. Considering the estimated 
prevalence of hepatitis in each country, we recommend that 
most immigrants, with the exception of those from Japan, 
should be tested for HAV immunity before vaccination. How-
ever, immigrants from Japan might be vaccinated without anti-
body testing in the age group under 40 years, as in Korean adults 
younger than 30 years of age.
Overall, 5.4% (n=52) of female marriage immigrants were 
positive for HBsAg, and anti-HBs was found in 60.4% (n=582). 
Sixty-two percent of countries in East, Southeast, and Central 
Asia have implemented universal HBV vaccination since 
1990. These countries have achieved more than 70% coverage 
of completed HBV vaccination (China, 99%; Thailand, 99%; 
Cambodia, 97%; Vietnam, 95%; the Philippines, 79%; Uzbeki-
stan, 82%, Mongolia, 76%).28-31 Therefore, the prevalence of an-
ti-HBs gradually increased in East, Southeast, and Central Asia 
after implementation of universal HBV vaccination program.
As in the case of HAV infection, no subject with HBsAg was 
found in immigrants from Japan; however, seroprevalence of 
HBsAg positive was 5% higher compared to those from Viet-
nam and Cambodia. Likewise, in systematic review and pooled 
analysis, Vietnam (10.8%) and Mongolia (9.1%) showed the 
highest endemicity (HBsAg prevalence ≥8%). Uzbekistan 
(7%), Thailand (6.4%), Kazakhstan (6.1%), and China (5.5%) 
were of higher-intermediate endemicity (HBsAg prevalence 
5–7.99%). The Philippines (4.6%), Korea (4.4%), and Cambo-
dia (4.1%) were of lower-intermediate endemicity (HBsAg 
prevalence 2–4.99%). Japan (1%) had the lowest level of ende-
micity (HBsAg prevalence <2%).32
We assumed that most HBsAg-positive individuals were in-
fected in their own countries, but we did not know the mode 
or time of infection. Fewer than 10% of immunocompetent 
adults, who were infected with HBV, developed chronic infec-
tion; however, 80–90% of perinatal transmission of HBV infec-
tion remains chronic.33 In this study, 50% (n=14) of HBsAg-
positive subjects with written informed consent about HBV 
DNA genotyping (n=28) showed elevated HBV DNA levels 
higher than 10000 copies/mL. Especially, 35.7% (n=10) of HB-
sAg-positive subjects required antiviral therapy. This is high-
lighted by the fact that HBV-infected female marriage immi-
grants with immune active phase or immune escape phase were 
sexually active women of childbearing age, who were highly 
likely to become pregnant. 
In Korean National Health and Nutritional Examination Sur-
vey 2014, HBsAg-positive rates were 1.7% in female subjects 
20–29 years and 3.2% in female subjects 30–39 years.34 In this 
study, HBsAg-positive rates in female marriage immigrants 
were 4.5% in 20–29 years and 5.7% in 30–40 years. Rate of HB-
sAg carriage was higher in female migrants than in Korean 
women. Moreover, 168853 children from multicultural fami-
lies were identified by the Ministry of Security and Public Ad-
ministration. A considerable number of children could have 
been exposed via mother-to-infant transmission. As men-
tioned, the number of female marriage immigrants was gradu-
ally increased.1 More than 80% of the immigrants came from 
HBV endemic areas, such as China (45301, 35.2%), Vietnam 
(40479, 31.5%), the Philippines (11272, 8.8%), Cambodia (4412, 
3.4%), and Thailand (3105, 2.4%). Therefore, early detection of 
HBV infection, through mass screening of HBV seromarkers, 
will induce timely and optimal antiviral therapy and finally 
prevent liver-related morbidity and mortality. In addition, ap-
propriate immunization in spouse is needed to prevent hori-
zontal infection. Perinatal care and health education on the 
prevention of vertical transmission should be covered by well-
organized health programs.
Furthermore, neither HBsAg nor anti-HBs were found in 329 
(34.2%) subjects who required HBV vaccination in our study. 
In previous reports about health exams supported by the Min-
istry of Health and Welfare in 2008, about 40% to 60% of immi-
grants wives were susceptible to HBV infection.35 However, 
available resources for HBV prevention targeting female mar-
riage migrants offer little access to health services.34 As with 
hepatitis A infection, efficacious and cheap vaccine is available 
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for HBV infection. Therefore, financial support and health ser-
vice for HBV vaccination should be provided to unimmunized 
immigrants.
Genotypes B and C are prevalent in Asian Pacific regions, 
and the prevailing HBV genotype in Korea is C.17,18 When HBV 
infections were compared, with respect to genotypes B and C, 
infection via genotype C showed higher incidence of progres-
sion to cirrhosis and hepatocellular carcinoma, less favorable 
HBeAg seroconversion response to standard or pegylated in-
terferon, and lower incidence of HBsAg seroclearance.15,16,36,37 
In our study, 22 strains were available in the analysis of HBV 
genotypes. Their phylogenic tree only showed genotypes B 
(54.6%, n=12) and C (45.4%, n=10). Genotype C was found in 
eight out of 10 subjects from China, and genotype B was found 
in seven out of nine subjects from Vietnam. Such finding is 
consistent with those of previous reports.16 Geographic differ-
ences have not affected the distribution of HBV genotype in 
Korea,17,18 while an epidemiological study conducted in China 
showed that genotypes B was primarily distributed in the south 
and genotype C in the north of the country.38 With the increase 
in incidence of transnational marriage, infection with geno-
type B could increase if we do not implement certain measures, 
such as screening and appropriate vaccination. HBV genotype 
is an important determinant in management. Therefore, medi-
cal expenses might increase to discriminate genotype for an 
individualized approach.
Estimated prevalence of anti-HCV positive rate in China 
was 1–1.9%. In a recent report using an estimated 2009 popu-
lation of Korea, the age, sex, and area-adjusted anti-HCV posi-
tive rate was 0.78%.20 Age-related prevalence of anti-HCV pos-
itive was 0.34% in subjects aged 20 to 29 years, and 0.41% in 
subjects aged 30 to 39 years.20 Our study showed that eight 
(0.8%) out of 963 subjects were positive for anti-HCV. Rates of 
anti-HCV positive in female marriage immigrants were 0.8% 
in 20–29 year-olds and 0.9% in 30–40 year-olds. Rate of anti-
HCV positive was also higher in female migrants than in Ko-
rean women. 
A systematic study showed that the estimated prevalence of 
HCV in the entire Asian continent was 2.8% (Japan, 1.5%; the 
Philippines, 0.8%; Cambodia, 2.5%; Thailand, 2.7%; Uzbeki-
stan, 11.3%; Mongolia, 8.5%; Kazakhstan, 2.9%).39 Although the 
prevalence of HCV was lower than that of HBV, most countries 
showed higher prevalence rate compared to Korea.
The present study had several limitations. First, it is impos-
sible to know the mode and time of infection, since serologic 
tests were not conducted at the time of immigration or mar-
riage, and subjects did not have reliable immunization re-
cords. However, we can assume that most hepatitis infections 
were acquired in the subjects’ own countries, based on our re-
sults concerning seroprevalence and distribution of genotypes. 
Second, although many immigrants in transnational marriag-
es reside in urban areas, other rural areas may show different 
patterns of seroepidemiology depending on subjects’ home 
countries. However, authors tried to include urban and rural 
immigrants in the same proportion. Third, despite a consider-
able number of subjects participating in the screening pro-
gram, numerous countries were represented by multicultural 
families, and analysis according to each country was infeasible 
in most cases. Therefore, it was difficult to ensure representa-
tive character. Fourth, a better knowledge based on gross na-
tional product and ethnicity may be critical for a complete 
understanding of the seroprevalence of hepatitis viruses. In 
addition, female marriage migrants also face financial difficul-
ties in Korea. More than half of them fall below poverty levels 
(www.korea.kr/common/download.do?tblKey=EDN& fileId= 
211426).40 Furthermore, female marriage immigrants have 
limited access to healthcare services and support, due to lin-
guistic barrier and economic difficulties.35 Finally, greater in-
vestment will be needed in public health research to evaluate 
the prevalence of seromarkers of hepatitis E virus in immi-
grants from high endemic areas, as well as the prevalence of 
HBV and hepatitis D virus coinfection in North Korean immi-
grants.
This survey is the first seroepidemiological analysis of hepa-
titis viruses and HBV genotypes in female marriage immi-
grants in Korea. Testing for hepatitis viral marker (HAV IgG and 
HBsAg/anti-HBs) is needed for female marriage immigrants. 
Especially, HBV genotype B is different from genotype C of 
Koreans. As the number of transnational marriages increases, 
interest and attention to vaccination program for female mar-
riage immigrants is required for both clinicians and public 
health institutes.
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